HUE040387T2 - Piridopirimidin-származékok - Google Patents

Piridopirimidin-származékok

Info

Publication number
HUE040387T2
HUE040387T2 HUE15840871A HUE15840871A HUE040387T2 HU E040387 T2 HUE040387 T2 HU E040387T2 HU E15840871 A HUE15840871 A HU E15840871A HU E15840871 A HUE15840871 A HU E15840871A HU E040387 T2 HUE040387 T2 HU E040387T2
Authority
HU
Hungary
Prior art keywords
pyridopyrimidines
derivatives
Prior art date
Application number
HUE15840871A
Other languages
English (en)
Inventor
Nucci Gilberto De
Original Assignee
Biolab Sanus Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Sanus Farmaceutica Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Publication of HUE040387T2 publication Critical patent/HUE040387T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUE15840871A 2014-09-12 2015-09-11 Piridopirimidin-származékok HUE040387T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462049506P 2014-09-12 2014-09-12

Publications (1)

Publication Number Publication Date
HUE040387T2 true HUE040387T2 (hu) 2019-03-28

Family

ID=55454107

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15840871A HUE040387T2 (hu) 2014-09-12 2015-09-11 Piridopirimidin-származékok

Country Status (18)

Country Link
US (2) US10280162B2 (hu)
EP (1) EP3191099B1 (hu)
JP (1) JP6661606B2 (hu)
KR (1) KR20170054408A (hu)
CN (2) CN107074847A (hu)
AR (1) AR101813A1 (hu)
AU (1) AU2015316120B2 (hu)
BR (1) BR112017004919A2 (hu)
CA (1) CA2958331C (hu)
CL (1) CL2017000582A1 (hu)
CO (1) CO2017001709A2 (hu)
ES (1) ES2701273T3 (hu)
HU (1) HUE040387T2 (hu)
IL (1) IL250968B (hu)
MX (1) MX2017003067A (hu)
PL (1) PL3191099T3 (hu)
PT (1) PT3191099T (hu)
WO (1) WO2016037255A2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022465A1 (en) 2014-08-04 2016-02-11 Drexel University Novel compounds and methods of treating or ameliorating an il-1r-mediated disease or disorder using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313736B1 (en) * 2000-06-26 2005-07-27 Lilly Icos LLC Condensed pyrazindione derivatives as inhibitors of pde5
BR0113628A (pt) 2000-08-31 2003-07-01 Hoffmann La Roche 7-oxo-piridopirimidinas como inibidores de uma proliferação celular
US6960587B2 (en) * 2000-11-08 2005-11-01 Lilly Icos Llc Condensed pyrazindione derivatives as PDE inhibitors
FR2896246B1 (fr) * 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
ES2344086T3 (es) * 2006-05-23 2010-08-17 F. Hoffmann-La Roche Ag Derivados de piridopirimidinona.
US20100035867A1 (en) * 2006-07-11 2010-02-11 Guerrant Richard L Inhibitors of Cyclic Nucleotide Synthesis and Their Use for Therapy of Various Diseases
US7474231B2 (en) * 2006-07-12 2009-01-06 Alcatel-Lucent Usa Inc. Radio communications for vehicle speed adjustment
UY33535A (es) * 2010-08-13 2011-12-01 Biolab Sanus Farmaceutuca Limitada Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona
WO2013183016A1 (en) * 2012-06-06 2013-12-12 L'oreal Active compounds for combating greasy skin

Also Published As

Publication number Publication date
MX2017003067A (es) 2017-06-14
JP6661606B2 (ja) 2020-03-11
IL250968A0 (en) 2017-04-30
CL2017000582A1 (es) 2017-11-24
IL250968B (en) 2020-03-31
WO2016037255A3 (en) 2016-06-30
ES2701273T3 (es) 2019-02-21
PL3191099T3 (pl) 2019-07-31
CA2958331C (en) 2019-12-17
AU2015316120A1 (en) 2017-01-12
EP3191099A2 (en) 2017-07-19
US20190218216A1 (en) 2019-07-18
CN107074847A (zh) 2017-08-18
US10280162B2 (en) 2019-05-07
KR20170054408A (ko) 2017-05-17
AU2015316120B2 (en) 2018-05-17
US20180111926A2 (en) 2018-04-26
US10822333B2 (en) 2020-11-03
US20160075702A1 (en) 2016-03-17
EP3191099B1 (en) 2018-11-14
AR101813A1 (es) 2017-01-11
CO2017001709A2 (es) 2017-03-31
CA2958331A1 (en) 2016-03-17
CN114751905A (zh) 2022-07-15
WO2016037255A2 (en) 2016-03-17
BR112017004919A2 (pt) 2017-12-12
PT3191099T (pt) 2018-12-18
JP2017526666A (ja) 2017-09-14

Similar Documents

Publication Publication Date Title
SG11201706729SA (en) Derivatives of sobetirome
IL263050B (en) History of Subtirum
SI3524234T1 (sl) Trdne oblike sofosbuvira
SG11201609205WA (en) Heterocyclyl-butanamide derivatives
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
IL246979A0 (en) Crystalline forms of sofosbuvir
PL3418273T3 (pl) Pochodne flawaglin
IL248773A0 (en) History of naphthyridinedione
IL248629B (en) Substances containing diheteroaryl conjugated to cycloalkyl and their uses
PT3097076T (pt) Novos derivados cyp-eicosanoides
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
IL249130B (en) Preparation of piperidine-4-carbothioamide
SG11201605072VA (en) Azaindole derivative
IL250968A0 (en) New compounds derived from pyridopyrimidines
IL249332A0 (en) Crystalline forms of sofosbuvir